Document is current

Any future updates will be listed below

Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling

Crossref DOI link: https://doi.org/10.1007/s13402-025-01128-8

Published Online: 2025-12-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark